E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/8/2005 in the Prospect News Biotech Daily and Prospect News PIPE Daily.

New Issue: Lpath Therapeutics raises $6 million from private placement of units

By Sheri Kasprzak

New York, Dec. 8 - Lpath Therapeutics Inc. said it has completed a private placement of units for $6 million.

The company issued 3.75 million units at $1.60 each to a group of investors led by Roaring Fork Capital SBIC, LP.

The units are comprised of two shares and one warrant. The warrants are exercisable for 58 months at $1.50 each.

The offering was completed as part of its merger with Neighborhood Connections, Inc. The merger was completed on Nov. 30. Under the merger terms, each outstanding share of Lpath was converted into one class A share of Neighborhood Connections.

The company's name was changed to Lpath Inc.

Based in San Diego, Lpath is a biopharmaceutical company focused on treatments for cardiovascular disorders, cancer and other disorders.

Issuer:Lpath Therapeutics Inc.
Issue:Units of two shares and one warrant
Amount:$6 million
Units:3.75 million
Price:$1.60
Warrants:One warrant per unit
Warrant expiration:58 months
Warrant strike price:$1.50
Investors:Roaring Fork Capital SBIC, LP (lead)
Settlement date:Dec. 8

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.